Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT06695325Recruiting

Convenient Home Access for Routine Monitoring in Diabetes (Charm-D Study)

Role: lead

NCT04653545Completed

Diabetes Diagnosis During Acute Admissions (FIND-IT)

Role: lead

NCT04732208Completed

Automated Screening of Diabetic Retinopathy Using a Smartphone-based Camera

Role: lead

NCT05240196Not ApplicableCompleted

Binaural Music Study

Role: lead

NCT04386044Completed

Investigating the Role of Vitamin D in the Morbidity of COVID-19 Patients

Role: lead

NCT02435329Completed

Microcirculation and Bone Metabolism in Patients With Type 2 Diabetes Mellitus and Charcot Foot - A Pilot Study

Role: lead

All 6 trials loaded